RxDoctor Payments Data

John Angle, MD

Vascular & Interventional Radiology · Charlottesville, VANPI 1609925007

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 53.8% of the total. Reporting peaked in 2021 at $3,770 and has fallen 95.4% since, to $173 in 2025.

$7,964in general payments, 2019–2025

Across 52 payments — averaging $153.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$4K
  • Boston Scientific$756
  • Medtronic$566
  • Penumbra, Inc.$439
  • Cook Medical LLC$353
  • Abbott$289
  • plus $1K from 12 others
$90,584in research payments, 2019–2025

Across 29 payments — averaging $3123.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Siemens Medical Solutions USA, Inc.$30K
  • Bolton Medical Inc$22K
  • Boston Scientific$12K
  • Cook Research Incorporated$11K
  • Philips North America LLC$9K
  • Dova Pharmaceuticals$7K

What the payments were for

  • Consulting fees$3,75047%
  • Grants$270%
  • Travel & lodging$7379%
  • Food & beverage$3,45143%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,964 in reported general payments places this provider in the 75th percentile of 136 vascular & interventional radiology providers in Virginia.

See all vascular & interventional radiology providers in Virginia

Medicare billing

Part B allowed, 2024
$110,901
Medicare patients
405
Services billed
3,713

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →